<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39560821</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-7403</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>19</Day></PubDate></JournalIssue><Title>Pituitary</Title><ISOAbbreviation>Pituitary</ISOAbbreviation></Journal><ArticleTitle>Hypopituitarism and COVID-19.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11102-024-01463-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This review aims to collect and examine recent research findings regarding hypopituitarism and COVID-19, focusing on the virus's impact on the pituitary gland and the outcomes for infected patients with hormonal deficiencies.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature review using PubMed (pubmed.ncbi.nlm.nih.gov). The search included the following terms: "COVID19" in combination with "Pituitary" and "Hypopituitarism".</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Many studies have aimed to evaluate the function of the pituitary gland in infected patients, revealing variable degrees of deficiencies. The results are very heterogenous mostly because many different tests and hormonal cut-off have been adopted. It is unclear whether primary virus damage or the inflammatory response is responsible for these hormonal alterations. Interestingly, pituitary defects may persist long after the initial infection, possibly contributing to the "Long COVID syndrome". However, data on the recovery of pituitary function and long-term follow-up are not yet available. On the other hand, although findings are not consistent, patients with hypopituitarism may be at a higher risk for COVID-19 infection rate, complications, and mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The COVID-19 pandemic presented challenges for endocrinologists. The endocrine system appears to be involved in both the acute phase of infection and the recovery period. Hypopituitarism can be a consequence of SARS-COV-2 infection, and patients with existing hypopituitarism may face higher risks of complications. It is advisable to educate these patients on how to adjust their replacement therapies. Long-term follow-up data on pituitary function after recovery from COVID-19 are needed.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carosi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cremaschi</LastName><ForeName>Arianna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giavoli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantovani</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Endocrinology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. giovanna.mantovani@unimi.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. giovanna.mantovani@unimi.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pituitary</MedlineTA><NlmUniqueID>9814578</NlmUniqueID><ISSNLinking>1386-341X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GHD</Keyword><Keyword MajorTopicYN="N">Hypopituitarism</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Pituitary apoplexy</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39560821</ArticleId><ArticleId IdType="doi">10.1007/s11102-024-01463-3</ArticleId><ArticleId IdType="pii">10.1007/s11102-024-01463-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497&#x2013;506. https://doi.org/10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId><ArticleId IdType="pmc">7159299</ArticleId></ArticleIdList></Reference><Reference><Citation>Frara S, Loli P, Allora A et al (2022) COVID-19 and hypopituitarism. Rev Endocr Metab Disord 23:215&#x2013;231. https://doi.org/10.1007/s11154-021-09672-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09672-y</ArticleId><ArticleId IdType="pubmed">34387832</ArticleId></ArticleIdList></Reference><Reference><Citation>Das L, Dutta P, Walia R et al (2021) Spectrum of Endocrine Dysfunction and Association with Disease Severity in patients with COVID-19: insights from a cross-sectional, observational study. Front Endocrinol 12:645787. https://doi.org/10.3389/fendo.2021.645787</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.645787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ach T, Ben Haj Slama N, Gorchane A et al (2024) Explaining long COVID: a Pioneer Cross-sectional Study supporting the endocrine hypothesis. J Endocr Soc 8:bvae003. https://doi.org/10.1210/jendso/bvae003</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvae003</ArticleId><ArticleId IdType="pubmed">38260089</ArticleId><ArticleId IdType="pmc">10801829</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A (2021) COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72:301&#x2013;316. https://doi.org/10.1007/s12020-021-02734-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02734-w</ArticleId><ArticleId IdType="pubmed">33963516</ArticleId><ArticleId IdType="pmc">8105151</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Giustina A (2020) COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68:2&#x2013;5. https://doi.org/10.1007/s12020-020-02294-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02294-5</ArticleId><ArticleId IdType="pubmed">32279224</ArticleId><ArticleId IdType="pmc">7150529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, He L, Zhang Q et al (2004) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203:622&#x2013;630. https://doi.org/10.1002/path.1560</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId><ArticleId IdType="pmc">7167761</ArticleId></ArticleIdList></Reference><Reference><Citation>Han T, Kang J, Li G et al (2020) Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study. Ann Transl Med 8:1077&#x2013;1077. https://doi.org/10.21037/atm-20-4281</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-4281</ArticleId><ArticleId IdType="pubmed">33145296</ArticleId><ArticleId IdType="pmc">7576005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzek A, Gerling M, P&#xfc;schel K, Saeger W (2022) Post-mortem histopathology of pituitary and adrenals of COVID-19 patients. Leg Med 57:102045. https://doi.org/10.1016/j.legalmed.2022.102045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.legalmed.2022.102045</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R (2020) COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine 68:251&#x2013;252. https://doi.org/10.1007/s12020-020-02325-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType="pubmed">32346813</ArticleId><ArticleId IdType="pmc">7186765</ArticleId></ArticleIdList></Reference><Reference><Citation>Siejka A, Barabutis N (2021) Adrenal insufficiency in the COVID-19 era. Am J Physiol-Endocrinol Metab 320:E784&#x2013;E785. https://doi.org/10.1152/ajpendo.00061.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00061.2021</ArticleId><ArticleId IdType="pubmed">33825496</ArticleId><ArticleId IdType="pmc">8057305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM et al (2021) The S1 protein of SARS-CoV-2 crosses the blood&#x2013;brain barrier in mice. Nat Neurosci 24:368&#x2013;378. https://doi.org/10.1038/s41593-020-00771-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonen MS, De Bellis A, Durcan E et al (2022) Assessment of neuroendocrine changes and hypothalamo-pituitary autoimmunity in patients with COVID-19. Horm Metab Res 54:153&#x2013;161. https://doi.org/10.1055/a-1764-1260</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1764-1260</ArticleId><ArticleId IdType="pubmed">35276740</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW et al (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63:197&#x2013;202. https://doi.org/10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres D, D&#xed;az-Rodr&#xed;guez C, Armentia-Medina A (2022) Anti-ACTH antibodies in critically ill Covid-19 patients: a potential immune evasion mechanism of SARS-CoV-2. Med Intensiva Engl Ed 46:472&#x2013;474. https://doi.org/10.1016/j.medine.2021.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medine.2021.09.001</ArticleId><ArticleId IdType="pubmed">35868721</ArticleId><ArticleId IdType="pmc">9295377</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuschlein F (2024) European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. J Clin Endocrinol 109</Citation></Reference><Reference><Citation>Foisy M, Yakiwchuk E, Chiu I, Singh A (2008) Adrenal suppression and Cushing&#x2019;s syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 9:389&#x2013;396. https://doi.org/10.1111/j.1468-1293.2008.00579.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1293.2008.00579.x</ArticleId><ArticleId IdType="pubmed">18459946</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xe9;blick A, Gunst J, Van Den Berghe G (2022) Critical illness&#x2013;induced corticosteroid insufficiency: what it is not and what it could be. J Clin Endocrinol Metab 107:2057&#x2013;2064. https://doi.org/10.1210/clinem/dgac201</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac201</ArticleId><ArticleId IdType="pubmed">35358303</ArticleId><ArticleId IdType="pmc">9202732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar B, Gopalakrishnan M, Garg M et al (2021) Endocrine dysfunction among patients with COVID-19: a single-center experience from a tertiary hospital in India. Indian J Endocrinol Metab 25:14. https://doi.org/10.4103/ijem.IJEM_577_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijem.IJEM_577_20</ArticleId><ArticleId IdType="pubmed">34386388</ArticleId><ArticleId IdType="pmc">8323627</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E, Karaca Z, Unuvar GK et al (2022) Investigation of pituitary functions after acute coronavirus disease 2019. Endocr J 69:649&#x2013;658. https://doi.org/10.1507/endocrj.EJ21-0531</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ21-0531</ArticleId><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Pastores SM, Rochwerg B et al (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): society of critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med 43:1751&#x2013;1763. https://doi.org/10.1007/s00134-017-4919-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4919-5</ArticleId><ArticleId IdType="pubmed">28940011</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleseriu M, Hashim IA, Karavitaki N et al (2016) Hormonal replacement in hypopituitarism in adults: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:3888&#x2013;3921. https://doi.org/10.1210/jc.2016-2118</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2016-2118</ArticleId><ArticleId IdType="pubmed">27736313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan T, Khoo B, Mills EG et al (2020) Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol 8:659&#x2013;660. https://doi.org/10.1016/S2213-8587(20)30216-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30216-3</ArticleId><ArticleId IdType="pubmed">32563278</ArticleId><ArticleId IdType="pmc">7302794</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua MWJ, Chua MPW (2021) Delayed onset of Central Hypocortisolism in a patient recovering from COVID-19. AACE Clin Case Rep 7:2&#x2013;5. https://doi.org/10.1016/j.aace.2020.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aace.2020.11.001</ArticleId><ArticleId IdType="pubmed">33521254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K, Nishigaki T, Kuramoto N et al (2022) Secondary adrenal insufficiency after COVID-19 diagnosed by insulin tolerance test and corticotropin-releasing hormone test. https://doi.org/10.7759/cureus.23021 . Cureus</Citation></Reference><Reference><Citation>Yoshimura K, Yamamoto M, Inoue T et al (2022) Coexistence of growth hormone, adrenocorticotropic hormone, and testosterone deficiency associated with coronavirus disease 2019: a case followed up for 15 months. Endocr J 69:1335&#x2013;1342. https://doi.org/10.1507/endocrj.EJ22-0108</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0108</ArticleId><ArticleId IdType="pubmed">35831125</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P et al (2021) Severely low testosterone in males with COVID-19: a case&#x2010;control study. Andrology 9:1043&#x2013;1052. https://doi.org/10.1111/andr.12993</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12993</ArticleId><ArticleId IdType="pubmed">33635589</ArticleId><ArticleId IdType="pmc">8013327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M, Dutta D, Anne B et al (2014) Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications. Diabetes Metab Syndr Obes Targets Ther 481. https://doi.org/10.2147/DMSO.S50777</Citation></Reference><Reference><Citation>Dhindsa S, Zhang N, McPhaul MJ et al (2021) Association of Circulating Sex Hormones with Inflammation and disease severity in patients with COVID-19. JAMA Netw Open 4:e2111398. https://doi.org/10.1001/jamanetworkopen.2021.11398</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11398</ArticleId><ArticleId IdType="pubmed">34032853</ArticleId><ArticleId IdType="pmc">8150664</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaydin T, Sahin B, Dashdamirova S et al (2022) The association of free testosterone levels with coronavirus disease 2019. Andrology 10:1038&#x2013;1046. https://doi.org/10.1111/andr.13152</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13152</ArticleId><ArticleId IdType="pubmed">34994082</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonia A, Pontillo M, Capogrosso P et al (2023) Testosterone in males with COVID-19: a 12&#x2010;month cohort study. Andrology 11:17&#x2013;23. https://doi.org/10.1111/andr.13322</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13322</ArticleId><ArticleId IdType="pubmed">36251583</ArticleId></ArticleIdList></Reference><Reference><Citation>Facondo P, Maltese V, Delbarba A et al (2022) Case Report: hypothalamic amenorrhea following COVID-19 infection and review of literatures. Front Endocrinol 13:840749. https://doi.org/10.3389/fendo.2022.840749</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.840749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Zhong J, Jiang Y, Zhang J (2022) Associations between COVID-19 infection and sex steroid hormones. Front Endocrinol 13:940675. https://doi.org/10.3389/fendo.2022.940675</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.940675</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo B, Tan T, Clarke SA et al (2021) Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab 106:e803&#x2013;e811. https://doi.org/10.1210/clinem/dgaa830</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa830</ArticleId><ArticleId IdType="pubmed">33180932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lizzi M, Aric&#xf2; M, Carlone G et al (2022) Central Diabetes Insipidus: another rare complication of SARS-CoV-2 infection in children? Pediatr Infect Dis J 41:e448&#x2013;e448. https://doi.org/10.1097/INF.0000000000003632</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003632</ArticleId><ArticleId IdType="pubmed">35830512</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgar RA, Rasool A, Wani AI, Bashir MI (2021) Central diabetes insipidus (Infundibuloneuro hypophysitis): a late complication of COVID-19 infection. J Endocrinol Invest 44:2855&#x2013;2856. https://doi.org/10.1007/s40618-021-01627-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01627-z</ArticleId><ArticleId IdType="pubmed">34215999</ArticleId><ArticleId IdType="pmc">8253675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajevac H, Bachan M, Khan Z (2020) DIABETES INSIPIDUS AS A SYMPTOM OF COVID-19 INFECTION: CASE REPORT. Chest 158:A2576. https://doi.org/10.1016/j.chest.2020.09.172</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.09.172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh AB, Javaid MA, Sheikh AAE, Shekhar R (2021) Central adrenal insufficiency and diabetes insipidus as potential endocrine manifestations of COVID-19 infection: a case report. Pan Afr Med J 38:222. https://doi.org/10.11604/pamj.2021.38.222.28243</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.222.28243</ArticleId><ArticleId IdType="pubmed">34046127</ArticleId><ArticleId IdType="pmc">8140727</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh AB, Javed N, Sheikh AAE et al (2021) Diabetes insipidus and concomitant myocarditis: a late sequelae of COVID-19 infection. J Investig Med High Impact Case Rep 9:2324709621999954. https://doi.org/10.1177/2324709621999954</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709621999954</ArticleId><ArticleId IdType="pubmed">33686899</ArticleId><ArticleId IdType="pmc">7952841</ArticleId></ArticleIdList></Reference><Reference><Citation>Yavari A, Sharifan Z, Larijani B, Mosadegh Khah A (2022) Central diabetes insipidus secondary to COVID-19 infection: a case report. BMC Endocr Disord 22:134. https://doi.org/10.1186/s12902-022-01048-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-022-01048-w</ArticleId><ArticleId IdType="pubmed">35590312</ArticleId><ArticleId IdType="pmc">9117597</ArticleId></ArticleIdList></Reference><Reference><Citation>Briet C, Salenave S, Bonneville J-F et al (2015) Pituitary Apoplexy. Endocr Rev 36:622&#x2013;645. https://doi.org/10.1210/er.2015-1042</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2015-1042</ArticleId><ArticleId IdType="pubmed">26414232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhoelan S, Langerak T, Noack D et al (2019) Hypopituitarism after Orthohantavirus infection: what is currently known? Viruses 11:340. https://doi.org/10.3390/v11040340</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11040340</ArticleId><ArticleId IdType="pubmed">30974852</ArticleId><ArticleId IdType="pmc">6521286</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmain J, Jarebi M, Al-Salameh A et al (2022) Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital. Eur J Endocrinol 187:K19&#x2013;K25. https://doi.org/10.1530/EJE-22-0056</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-22-0056</ArticleId><ArticleId IdType="pubmed">35895701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordes SJ, Phang-Lyn S, Najera E et al (2021) Pituitary Apoplexy attributed to COVID-19 infection in the absence of an underlying Macroadenoma or Other Identifiable cause. https://doi.org/10.7759/cureus.13315 . Cureus</Citation></Reference><Reference><Citation>Martinez-Perez R, Kortz MW, Carroll BW et al (2021) Coronavirus Disease 2019 and Pituitary Apoplexy: a single-Center Case Series and Review of the literature. World Neurosurg 152:e678&#x2013;e687. https://doi.org/10.1016/j.wneu.2021.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.wneu.2021.06.004</ArticleId><ArticleId IdType="pubmed">34129968</ArticleId><ArticleId IdType="pmc">8196470</ArticleId></ArticleIdList></Reference><Reference><Citation>Solorio-Pineda S, Almend&#xe1;rez-S&#xe1;nchez CA, Tafur-Grandett AA et al (2020) Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome-coronavirus-2-positive testing: causal or casual? Surg Neurol Int 11:304. https://doi.org/10.25259/SNI_305_2020</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/SNI_305_2020</ArticleId><ArticleId IdType="pubmed">33093981</ArticleId><ArticleId IdType="pmc">7568102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen EC, Zon RL, Battinelli EM, Connors JM (2020) Approach to the patient with COVID-19-Associated thrombosis: a case-based review. Oncologist 25:e1500&#x2013;e1508. https://doi.org/10.1634/theoncologist.2020-0682</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2020-0682</ArticleId><ArticleId IdType="pubmed">32881209</ArticleId><ArticleId IdType="pmc">7461375</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezkalla SH, Kloner RA (2021) Post-acute Sequelae of SARS-COVID-2 syndrome: just the beginning. Cardiol Res 12:279&#x2013;285. https://doi.org/10.14740/cr1290</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/cr1290</ArticleId><ArticleId IdType="pubmed">34691325</ArticleId><ArticleId IdType="pmc">8510656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MM, Das J, Rahman F et al (2023) Living with long COVID: a systematic review and meta-synthesis of qualitative evidence. PLoS ONE 18:e0281884. https://doi.org/10.1371/journal.pone.0281884</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281884</ArticleId><ArticleId IdType="pubmed">36795701</ArticleId><ArticleId IdType="pmc">9934341</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102&#x2013;e107. https://doi.org/10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N et al (2023) Systematic review of the prevalence of long COVID. Open Forum Infect Dis 10:ofad233. https://doi.org/10.1093/ofid/ofad233</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId><ArticleId IdType="pmc">10316694</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Y-J, Liu S-H, Manachevakul S et al (2023) Biomarkers in long COVID-19: a systematic review. Front Med 10:1085988. https://doi.org/10.3389/fmed.2023.1085988</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId></ArticleIdList></Reference><Reference><Citation>Bancos I, Hazeldine J, Chortis V et al (2017) Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur J Endocrinol 176:471&#x2013;480. https://doi.org/10.1530/EJE-16-0969</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-16-0969</ArticleId><ArticleId IdType="pubmed">28223394</ArticleId><ArticleId IdType="pmc">5425935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tresoldi AS, Sumilo D, Perrins M et al (2019) Increased infection risk in Addison&#x2019;s disease and congenital adrenal hyperplasia. a primary care database cohort study</Citation></Reference><Reference><Citation>Jensterle M, Herman R, Jane&#x17e; A et al (2022) The relationship between COVID-19 and hypothalamic&#x2013;pituitary&#x2013;adrenal Axis: a large spectrum from glucocorticoid insufficiency to excess&#x2014;the CAPISCO International Expert Panel. Int J Mol Sci 23:7326. https://doi.org/10.3390/ijms23137326</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137326</ArticleId><ArticleId IdType="pubmed">35806331</ArticleId><ArticleId IdType="pmc">9266848</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergthorsdottir R, Esposito D, Olsson DS et al (2024) Increased risk of hospitalization, intensive care and death due to COVID-19 in patients with adrenal insufficiency: a Swedish nationwide study. J Intern Med 295:322&#x2013;330. https://doi.org/10.1111/joim.13731</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13731</ArticleId><ArticleId IdType="pubmed">37850585</ArticleId></ArticleIdList></Reference><Reference><Citation>Carosi G, Morelli V, Del Sindaco G et al (2021) Adrenal insufficiency at the Time of COVID-19: a retrospective study in patients referring to a Tertiary Center. J Clin Endocrinol Metab 106:e1354&#x2013;e1361. https://doi.org/10.1210/clinem/dgaa793</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa793</ArticleId><ArticleId IdType="pubmed">34932807</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf A, Marcus HJ, Baldeweg SE (2021) The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study. Pituitary 24:262&#x2013;268. https://doi.org/10.1007/s11102-020-01106-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-020-01106-3</ArticleId><ArticleId IdType="pubmed">33236181</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles G, Warmington E, Shepherd LM et al (2023) Impact of coronavirus disease 2019 on patients with primary adrenal insufficiency: a cross-sectional study. Endocr Connect 12:e230122. https://doi.org/10.1530/EC-23-0122</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-23-0122</ArticleId><ArticleId IdType="pubmed">37253239</ArticleId><ArticleId IdType="pmc">10388655</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino M, Aboud N, Cola MF et al (2021) Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study. J Endocrinol Invest 44:1075&#x2013;1084. https://doi.org/10.1007/s40618-020-01422-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01422-2</ArticleId><ArticleId IdType="pubmed">32946078</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowotny HF, Bryce J, Ali SR et al (2023) Outcome of COVID-19 infections in patients with adrenal insufficiency and excess. Endocr Connect 12:e220416. https://doi.org/10.1530/EC-22-0416</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-22-0416</ArticleId><ArticleId IdType="pubmed">36715679</ArticleId><ArticleId IdType="pmc">10083676</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;ster S, Esposito D, Aranda-Guill&#xe9;n M et al (2023) Self-management and hospitalization in 615 Swedish patients with Addison&#x2019;s disease during the coronavirus disease 2019 pandemic: a retrospective study. Eur J Endocrinol 188:189&#x2013;196. https://doi.org/10.1093/ejendo/lvad010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejendo/lvad010</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino A, Hasenmajer V, Newell-Price J, Isidori AM (2023) COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders. Endocrine 82:1&#x2013;14. https://doi.org/10.1007/s12020-023-03411-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03411-w</ArticleId><ArticleId IdType="pubmed">37338722</ArticleId><ArticleId IdType="pmc">10462567</ArticleId></ArticleIdList></Reference><Reference><Citation>Yedinak C, Ross IL (2022) Significant risk of COVID-19 and related-hospitalization among patients with adrenal insufficiency: a large multinational survey. Front Endocrinol 13:1042119. https://doi.org/10.3389/fendo.2022.1042119</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1042119</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Suresh M, Abbondanza T et al (2021) The impact of the COVID-19 pandemic on self-reported outcomes in patients with adrenal insufficiency. J Clin Endocrinol Metab 106:e2469&#x2013;e2479. https://doi.org/10.1210/clinem/dgab334</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab334</ArticleId><ArticleId IdType="pubmed">34042985</ArticleId><ArticleId IdType="pmc">8194854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbadin C, Falb MP, Voltan G et al (2024) Serological evidence and self-reported outcomes in patients with AdrenalInsufficiency during the first waves of COVID-19 in North-East Italy. https://doi.org/10.2174/1871530322666220811103755 . Endocr Metab Immune Disord - Drug Targets 24:</Citation></Reference><Reference><Citation>Brandi ML, Giustina A (2020) Sexual dimorphism of Coronavirus 19 morbidity and lethality. Trends Endocrinol Metab 31:918&#x2013;927. https://doi.org/10.1016/j.tem.2020.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2020.09.003</ArticleId><ArticleId IdType="pubmed">33082024</ArticleId><ArticleId IdType="pmc">7513816</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham H, De Gruijter NM, Raine C et al (2020) Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun 11:6317. https://doi.org/10.1038/s41467-020-19741-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId><ArticleId IdType="pmc">7726563</ArticleId></ArticleIdList></Reference><Reference><Citation>Baillargeon J, Kuo Y, Westra J et al (2022) Association of testosterone therapy with disease progression in older males with COVID-19. Andrology 10:1057&#x2013;1066. https://doi.org/10.1111/andr.13193</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.13193</ArticleId><ArticleId IdType="pubmed">35486968</ArticleId></ArticleIdList></Reference><Reference><Citation>Groti Antonic K, Antonic B, Caliber M, Dhindsa S (2024) Men, testosterone and Covid-19. Clin Endocrinol (Oxf) 100:56&#x2013;65. https://doi.org/10.1111/cen.14952</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.14952</ArticleId><ArticleId IdType="pubmed">37501254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas JM, Heinlein C, Kim T et al (2014) The androgen-regulated protease TMPRSS2 activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and promotes prostate Cancer Metastasis. Cancer Discov 4:1310&#x2013;1325. https://doi.org/10.1158/2159-8290.CD-13-1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-13-1010</ArticleId><ArticleId IdType="pubmed">25122198</ArticleId><ArticleId IdType="pmc">4409786</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa S, Champion C, Deol E et al (2022) Association of male hypogonadism with risk of hospitalization for COVID-19. JAMA Netw Open 5:e2229747. https://doi.org/10.1001/jamanetworkopen.2022.29747</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.29747</ArticleId><ArticleId IdType="pubmed">36053534</ArticleId><ArticleId IdType="pmc">9440397</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambhatla A, Bronkema CJ, Corsi N et al (2021) COVID-19 infection in men on testosterone replacement therapy. J Sex Med 18:215&#x2013;218. https://doi.org/10.1016/j.jsxm.2020.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsxm.2020.09.013</ArticleId><ArticleId IdType="pubmed">33191186</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SW, Kim J, Lee JH et al (2022) Hormone therapy in the era of the COVID-19 pandemic: a review. J Menopausal Med 28:1&#x2013;8. https://doi.org/10.6118/jmm.21036</Citation><ArticleIdList><ArticleId IdType="doi">10.6118/jmm.21036</ArticleId><ArticleId IdType="pubmed">35534425</ArticleId><ArticleId IdType="pmc">9086346</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeland U, Coluzzi F, Simmaco M et al (2020) Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med 18:369. https://doi.org/10.1186/s12916-020-01851-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01851-z</ArticleId><ArticleId IdType="pubmed">33234138</ArticleId><ArticleId IdType="pmc">7685778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-de-Arellano A, Guti&#xe9;rrez-Franco J, Sierra-Diaz E, Pereira-Su&#xe1;rez AL (2021) The role of estradiol in the immune response against COVID-19. Horm Athens Greece 20:657&#x2013;667. https://doi.org/10.1007/s42000-021-00300-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42000-021-00300-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Elenis E, Kallner HK, Karalexi MA et al (2024) Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden. BMC Med 22:84. https://doi.org/10.1186/s12916-024-03297-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-024-03297-z</ArticleId><ArticleId IdType="pubmed">38414048</ArticleId><ArticleId IdType="pmc">10898018</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnacci A, Bonaccorsi G, Gambacciani M et al (2020) Reflections and recommendations on the COVID-19 pandemic: should hormone therapy be discontinued? Maturitas 138:76&#x2013;77. https://doi.org/10.1016/j.maturitas.2020.05.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2020.05.022</ArticleId><ArticleId IdType="pubmed">32565009</ArticleId><ArticleId IdType="pmc">7301099</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitch ME, Clemmons DR, Malozowski S et al (2011) Evaluation and treatment of adult growth hormone Deficiency: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:1587&#x2013;1609. https://doi.org/10.1210/jc.2011-0179</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0179</ArticleId><ArticleId IdType="pubmed">21602453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubrano C, Masi D, Risi R et al (2020) Is growth hormone insufficiency the Missing Link between obesity, male gender, Age, and COVID-19 severity? Obesity 28:2038&#x2013;2039. https://doi.org/10.1002/oby.23000</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23000</ArticleId><ArticleId IdType="pubmed">32808459</ArticleId></ArticleIdList></Reference><Reference><Citation>Brill G, Manor I, Bril Paroz R et al (2022) The Association between Somatotropin Therapy and the risk of SARS-CoV-2 infection in children with short stature: a Population-based cross-sectional study. Children 9:1844. https://doi.org/10.3390/children9121844</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/children9121844</ArticleId><ArticleId IdType="pubmed">36553288</ArticleId><ArticleId IdType="pmc">9777504</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavoli C, Profka E, Giancola N et al (2020) Growth hormone therapy at the time of Covid-19 pandemic: adherence and drug supply issues. Eur J Endocrinol 183:L13&#x2013;L15. https://doi.org/10.1530/EJE-20-0481</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0481</ArticleId><ArticleId IdType="pubmed">32688337</ArticleId><ArticleId IdType="pmc">9494317</ArticleId></ArticleIdList></Reference><Reference><Citation>Christ-Crain M, Hoorn EJ, Sherlock M et al (2021) ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: the management of diabetes insipidus and hyponatraemia. Eur J Endocrinol 185:G35&#x2013;G42. https://doi.org/10.1530/EJE-21-0596</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-21-0596</ArticleId><ArticleId IdType="pubmed">34292875</ArticleId><ArticleId IdType="pmc">8428073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>